AI-generated summary
This single-center retrospective cohort study of 90 eyes with refractory meibomian gland dysfunction treated with intense pulsed light and gland expression over 6 months found that more severe symptoms, more inspissated meibum, better expressibility, and milder lid telangiectasia were independently associated with a favorable response. The authors report that patients with worse symptoms or poorer meibum quality were more likely to respond well.
- Participants
- 90
- Who or what was studied
- Patients with refractory meibomian gland dysfunction (90 eyes in 90 patients) treated with intense pulsed light therapy combined with meibomian gland expression
- Limits stated in the abstract
- The study is a single-center retrospective design with no control group, and the abstract does not describe how the findings would generalize to other populations.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.